The present invention relates to novel compounds of formula (I):
##STR1##
in which:
R1, R2 and R3, which are identical or different,
are each independently:
- a (C1-C6)alkyl group,
- a pyridinyl group or
- a group -CH2-NR4R5, in which R4
and R5 are each independently a hydrogen atom or a (C1-C4)alkyl
group, or alternatively R4 and R5 form, with the nitrogen
atom to which they are bonded, a pyrrolidinyl, piperidinyl, hexahydroazepinyl,
morpholinyl or piperazinyl group,
with the proviso that at least one of the substituents R1, R2
and R3 is other than a (C1-C6)alkyl group,
and their salts, solvates and hydrates, especially those which are pharmaceutically acceptable.
These compounds are useful particularly for the treatment of disorders of the
venous circulation.
|
|
|